These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 7511881

  • 1. Interferon treatment enhances the expression of underphosphorylated (biologically-active) retinoblastoma protein in human papilloma virus-infected cells through the inhibitory TGF beta 1/IFN beta cytokine pathway.
    Arany I, Rady P, Tyring SK.
    Antiviral Res; 1994 Feb; 23(2):131-41. PubMed ID: 7511881
    [Abstract] [Full Text] [Related]

  • 2. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA, Zhang D, Choo CK, Eckert RL, Jacobberger JW.
    Exp Cell Res; 2000 Aug 25; 259(1):149-57. PubMed ID: 10942587
    [Abstract] [Full Text] [Related]

  • 3. Interferon response depends on viral transcription in human papillomavirus-containing lesions.
    Arany I, Goel A, Tyring SK.
    Anticancer Res; 1995 Aug 25; 15(6B):2865-9. PubMed ID: 8669880
    [Abstract] [Full Text] [Related]

  • 4. Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells.
    Resnitzky D, Tiefenbrun N, Berissi H, Kimchi A.
    Proc Natl Acad Sci U S A; 1992 Jan 01; 89(1):402-6. PubMed ID: 1370354
    [Abstract] [Full Text] [Related]

  • 5. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
    Kirch HC, Putzer B, Brockmann D, Esche H, Kloke O.
    Eur J Biochem; 1997 Jun 15; 246(3):736-44. PubMed ID: 9219533
    [Abstract] [Full Text] [Related]

  • 6. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G, Liu W, Hanania EG, Fu S, Wang T, Deisseroth AB.
    Cancer Gene Ther; 1995 Mar 15; 2(1):19-32. PubMed ID: 7621252
    [Abstract] [Full Text] [Related]

  • 7. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
    Nees M, Geoghegan JM, Hyman T, Frank S, Miller L, Woodworth CD.
    J Virol; 2001 May 15; 75(9):4283-96. PubMed ID: 11287578
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts.
    Kim TA, Ravitz MJ, Wenner CE.
    J Cell Physiol; 1994 Jul 15; 160(1):1-9. PubMed ID: 8021288
    [Abstract] [Full Text] [Related]

  • 10. Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium.
    Ruesch MN, Laimins LA.
    Virology; 1998 Oct 10; 250(1):19-29. PubMed ID: 9770416
    [Abstract] [Full Text] [Related]

  • 11. Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells.
    Zhang K, Kumar R.
    Biochem Biophys Res Commun; 1994 Apr 15; 200(1):522-8. PubMed ID: 8166726
    [Abstract] [Full Text] [Related]

  • 12. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
    Nees M, Geoghegan JM, Munson P, Prabhu V, Liu Y, Androphy E, Woodworth CD.
    Cancer Res; 2000 Aug 01; 60(15):4289-98. PubMed ID: 10945644
    [Abstract] [Full Text] [Related]

  • 13. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC, DiMaio D.
    Proc Natl Acad Sci U S A; 2000 Nov 07; 97(23):12513-8. PubMed ID: 11070078
    [Abstract] [Full Text] [Related]

  • 14. Alterations in cytokine/antioncogene expression in skin lesions caused by "low-risk" types of human papillomaviruses.
    Arany I, Rady P, Tyring SK.
    Viral Immunol; 1993 Nov 07; 6(4):255-65. PubMed ID: 8166933
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R, Aqil F, Jeyabalan J, Gupta RC.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):536-46. PubMed ID: 25304375
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2.
    Darnell GA, Antalis TM, Rose BR, Suhrbier A.
    J Virol; 2005 Apr 28; 79(7):4246-56. PubMed ID: 15767426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.